KCNJ11 Gene Genetic Test for Non‑Insulin‑Dependent Diabetes Mellitus (NIDDM) in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين KCNJ11 لمرض السكري غير المعتمد على الأنسولين في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

📋 Executive Summary – UAE-Clinic Certified

✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
🏥 Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
🩺 Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA‑licensed specialists.
💳 Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

ملخص تنفيذي: دقة 99.9%، خدمة سحب منزلي ممتازة، استشارة طبية فورية بعد الفحص.

🔬 Overview

The KCNJ11 Genetic Test analyses the entire coding region of the KCNJ11 gene to identify pathogenic variants linked to non‑insulin‑dependent diabetes mellitus (NIDDM), enabling precise risk stratification and personalised lifestyle or pharmacologic interventions. يُحلل هذا الاختبار الجيني طفرات جين KCNJ11 المرتبطة بالسكري غير المعتمد على الأنسولين.

Parameter	Our Test (ISO – DHA Aligned)	Closest Alternative
Precision	99.9% analytical sensitivity / Full gene coverage	Targeted genotyping (limited SNPs)
Method	Next‑Generation Sequencing (NGS) + validated bioinformatics	Sanger sequencing of selected exons
Speed (TAT)	3–4 Weeks	4–6 Weeks

🩺 Physician Insight & Safety Protocol

“This genetic assay provides a powerful window into an individual’s predisposition to non‑insulin‑dependent diabetes. However, its results are never stand‑alone; they must be correlated with clinical presentation, family history, and metabolic markers. Any treatment adjustment must be guided by your treating doctor.”

— Dr. PRABHAKAR REDDY, Clinical Diabetologist, DHA License 61713011

⚠️ Medication Safety Warning

Do not discontinue, alter, or self‑adjust any prescribed diabetes medication without direct consultation with your attending physician. This test informs long‑term management, not acute therapy changes.

🚨 Exclusion Criteria & Emergency Red Flags

Test not intended for patients currently experiencing diabetic ketoacidosis or hyperosmolar hyperglycaemic state.
Not a substitute for standard diagnostic glucose monitoring – do not delay urgent care.
If you develop acute confusion, severe dehydration, rapid breathing, or loss of consciousness, proceed to the nearest emergency department immediately.

Regulatory Compliance: This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE’s CDS Law 2026 (Minors), and Federal PDPL for genetic data privacy. Laboratory license 9834453.

❓ Patient FAQ & Clinical Guidance

Q1: What exactly does this genetic test detect?

This genetic test identifies KCNJ11 gene mutations linked to non‑insulin‑dependent diabetes, guiding personalized treatment and family screening. Complete gene sequencing reveals variants that affect insulin secretion and beta‑cell function, helping your doctor stratify risk and tailor prevention.

س: ما الذي يكشفه هذا الاختبار الجيني بالتحديد؟

ج: يحدد هذا الاختبار الطفرات في جين KCNJ11 المرتبطة بالسكري غير المعتمد على الأنسولين، مما يوجه العلاج الشخصي وفحص أفراد العائلة.

Q2: Is any pre‑ preparation or fasting required?

No fasting or medication changes required; a genetic counseling session is recommended before sample collection. You can provide a blood sample, extracted DNA, or a drop of blood on an FTA card without altering your daily routine.

س: هل هناك حاجة لتحضيرات أو صيام قبل التحليل؟

ج: لا حاجة للصيام أو تغيير الأدوية؛ يُنصح بجلسة استشارة وراثية قبل جمع العينة.

Q3: How long until I receive my results?

Results ready within 3 to 4 weeks from sample receipt at our ISO‑certified lab. Turnaround time includes NGS sequencing, variant interpretation, and a verified report reviewed by a clinical geneticist.

س: كم من الوقت حتى تظهر النتائج؟

ج: تصدر النتائج خلال 3 إلى 4 أسابيع من استلام العينة في مختبرنا المعتمد الآيزو.

دعم ثنائي اللغة متاح